100.000 ncolonies nin nasymptomatic: nbacteruria
1. Urine
10 n- n10.000 ncolonies nin nsymptomatic npatients nbut
nculture nwith
nalso npyuria
nUTI
pyuria: nmore nthan n10 nleukocytes
nelevated nerythrocytes nwith
npyelonephritis nWBC nin nurine
false npositive nwith ntumor, nurethritis nand npoor ncollection
ntechnique
Repeat nin npregnant nwomen
bladder nand nurethra: ncystitis/ nurethritis/ nprostatitis
nkidney nand nureters: npyelonephritis/ nrenal nabcess
2. Lower nurinary
ntract nUTI nand
nup- nper nurinary
ntract nUTI
Uncomplicated: nin nnormal nworking nurinary ntract
nComplicated: ndefects nin nurinary ntract nor nwith nother nhealth
3. Uncomplicated
nproblems
nand
ncomplicated nuti
E.coli n(elderly nwomen)
Staphylococcus
4. Common
proteus nmirabilis n(elderly nmen)
npathogens
Klebsiella
nfor nUTI
nenterecoccus
npseudomonas
Providencia
n(institutionalized) nFungus:
ncandida
Female
5. Risk nfactors
ncritically nill
nfor nUTI
nelderly
catheter n(caused nby nbiofilm)
1 n/ n
122
,n
ic nbladder nWomen:
D
sexual nintercourse nor nnew nsex npartner
M
c
a
l
c
u
l
i
,
n
t
u
m
o
r
,
n
s
t
r
i
c
t
u
r
e
n
n
e
u
r
o
g
e
n
2 n/ n
122
, pregnancy
nprevious
nUTI nMen:
prostate nenlargement
nprostatitis
lack nof ncircumcision
ngay
HIV
6. Findings nUTI Lower:
Dysuria/ nurgency/ nfrequency/ nincontinence
nsuprapubic npain
hematuria
fever/ nchills nuncommon
nNo nflank npain
Upper:
flank npain
nfever nand
nchills
nhematuria
n/v
ams n(in nelderly)
nmalaise
tachycardia/ ntachypnea
7. Testing nand
nre- nsults nfor
nUTI
8. Management nacute ncystitis
3 n/ n
122
, Gold nstandard: n nUS npelvis
nurine nculture nMRI npelvis
nand nsensitivity:
ndetection nof First nline:
nbacteria. nStart - Single ndose nFosfomycin n(monurol)
nwith nPOC: - 3 nday: nsulfa: ntrimethoprim/ nsulfa n(bactrim) n(do nnot ngive
nurine nanalysis.
UA: npos nfor nnitrite nor
nleukocyte nor nblood
CBC: nleukocyte nwith
nleft nshift nin
npyelonephritis
For nrecurrent nUTI nin
nwomen nor nUTI nin
nmen nrule nout nob-
nstruction, ncalculi, nor
nnecrosis nwith:
x
r
n
v
o
i
d
i
n
g
n
C
T
n
a
b
d
o
m
e
4 n/ n
122
1. Urine
10 n- n10.000 ncolonies nin nsymptomatic npatients nbut
nculture nwith
nalso npyuria
nUTI
pyuria: nmore nthan n10 nleukocytes
nelevated nerythrocytes nwith
npyelonephritis nWBC nin nurine
false npositive nwith ntumor, nurethritis nand npoor ncollection
ntechnique
Repeat nin npregnant nwomen
bladder nand nurethra: ncystitis/ nurethritis/ nprostatitis
nkidney nand nureters: npyelonephritis/ nrenal nabcess
2. Lower nurinary
ntract nUTI nand
nup- nper nurinary
ntract nUTI
Uncomplicated: nin nnormal nworking nurinary ntract
nComplicated: ndefects nin nurinary ntract nor nwith nother nhealth
3. Uncomplicated
nproblems
nand
ncomplicated nuti
E.coli n(elderly nwomen)
Staphylococcus
4. Common
proteus nmirabilis n(elderly nmen)
npathogens
Klebsiella
nfor nUTI
nenterecoccus
npseudomonas
Providencia
n(institutionalized) nFungus:
ncandida
Female
5. Risk nfactors
ncritically nill
nfor nUTI
nelderly
catheter n(caused nby nbiofilm)
1 n/ n
122
,n
ic nbladder nWomen:
D
sexual nintercourse nor nnew nsex npartner
M
c
a
l
c
u
l
i
,
n
t
u
m
o
r
,
n
s
t
r
i
c
t
u
r
e
n
n
e
u
r
o
g
e
n
2 n/ n
122
, pregnancy
nprevious
nUTI nMen:
prostate nenlargement
nprostatitis
lack nof ncircumcision
ngay
HIV
6. Findings nUTI Lower:
Dysuria/ nurgency/ nfrequency/ nincontinence
nsuprapubic npain
hematuria
fever/ nchills nuncommon
nNo nflank npain
Upper:
flank npain
nfever nand
nchills
nhematuria
n/v
ams n(in nelderly)
nmalaise
tachycardia/ ntachypnea
7. Testing nand
nre- nsults nfor
nUTI
8. Management nacute ncystitis
3 n/ n
122
, Gold nstandard: n nUS npelvis
nurine nculture nMRI npelvis
nand nsensitivity:
ndetection nof First nline:
nbacteria. nStart - Single ndose nFosfomycin n(monurol)
nwith nPOC: - 3 nday: nsulfa: ntrimethoprim/ nsulfa n(bactrim) n(do nnot ngive
nurine nanalysis.
UA: npos nfor nnitrite nor
nleukocyte nor nblood
CBC: nleukocyte nwith
nleft nshift nin
npyelonephritis
For nrecurrent nUTI nin
nwomen nor nUTI nin
nmen nrule nout nob-
nstruction, ncalculi, nor
nnecrosis nwith:
x
r
n
v
o
i
d
i
n
g
n
C
T
n
a
b
d
o
m
e
4 n/ n
122
